Telomir Pharmaceuticals
TELO
#8448
Rank
NZ$0.27 B
Marketcap
$9.17
Share price
14.10%
Change (1 day)
N/A
Change (1 year)

EPS for Telomir Pharmaceuticals (TELO)

EPS in 2023 (TTM): -$0.20

According to Telomir Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.21. In 2022 the company made an earnings per share (EPS) of -$0.05106 a decrease over its 2021 EPS that were of -$0.008258.

EPS history for Telomir Pharmaceuticals from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.20292.14%
2022-$0.05106518.37%
2021-$0.008258